<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02238990</url>
  </required_header>
  <id_info>
    <org_study_id>UKSH-HL-14-099</org_study_id>
    <secondary_id>UKSH-HL-14-099</secondary_id>
    <nct_id>NCT02238990</nct_id>
  </id_info>
  <brief_title>Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions</brief_title>
  <official_title>Biomarkerscreening Via Transcriptome and Methylosome Analysis in Cervical Cancer and Its Preinvasive Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The following trial is a multicenter and prospective research trial of the colposcopy unit of
      luebeck university and the national research center in Borstel, Germany.

      The study is to identify and evaluate new biomarkers in human papilloma virus (HPV)
      associated malignancies and its preinvasive lesions of the cervix uteri. Fresh tissue samples
      being removed during conizations and/or hysterectomies are to be fixed in HOPE`s solution and
      analyzed according to their transcriptomes and methylosome. The hereby found candidates are
      to be validated using immunohistochemistry and RT [real-time] -PCR [polymerase chain
      reaction].

      The project is meant to be followed by continuous studies developing a new test describing
      the malignant potential of HPV associated genital lesions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CIN III (cervical intraepithelial neoplasia) lesions</measure>
    <time_frame>three years</time_frame>
    <description>number of CIN III lesions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cervical cancer</measure>
    <time_frame>three years</time_frame>
    <description>number of cervical cancer probes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HPV</measure>
    <time_frame>three years</time_frame>
    <description>number and type of HPV infection of the analyzed probes</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Evaluation of New Tissue Biomarkers for Cervical Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      tissue samples of the cervix uteri
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The population is to be recruted from A. patients suffering from cervical cancer B.
        patients suffering from preinvasive cervical lesions
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive informed consent

          -  Patients with suspected preinvasive genital lesion

          -  Patients with confirmed genital lesion (both preinvasive and invasive)

          -  Contact via dept. of obs/gyn of luebeck university

          -  Complete set of data

        Exclusion Criteria:

          -  Incomplete set of data

          -  Negative informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Beyer, PD Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Luebeck</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torsten Goldmann, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Forschungszentrum Borstel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Beyer, PD Dr.</last_name>
    <phone>+49 451 500 2141</phone>
    <email>daniel.beyer@uksh.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Luebeck University, Department for obstetrics and gynecology</name>
      <address>
        <city>Luebeck</city>
        <state>Schleswig Holstein</state>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Beyer, PD Dr.</last_name>
      <phone>+49 451 500 2141</phone>
      <email>daniel.beyer@uksh.de</email>
    </contact>
    <contact_backup>
      <last_name>Torsten Goldmann, Prof. Dr.</last_name>
      <phone>+ 49 4537 188 230</phone>
      <email>tgoldmann@fz-borstel.de</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Beyer, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Torsten Goldmann, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Apgar BS, Kittendorf AL, Bettcher CM, Wong J, Kaufman AJ. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Physician. 2009 Jul 15;80(2):147-55.</citation>
    <PMID>19621855</PMID>
  </reference>
  <reference>
    <citation>Gagn√© HM. Colposcopy of the vagina and vulva. Obstet Gynecol Clin North Am. 2008 Dec;35(4):659-69; x. doi: 10.1016/j.ogc.2008.10.002. Review.</citation>
    <PMID>19061824</PMID>
  </reference>
  <reference>
    <citation>Massad LS, Jeronimo J, Katki HA, Schiffman M; National Institutes of Health/American Society for Colposcopy and Cervical Pathology Research Group. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2009 Jul;13(3):137-44. doi: 10.1097/LGT.0b013e31819308d4.</citation>
    <PMID>19550210</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2014</study_first_submitted>
  <study_first_submitted_qc>September 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2014</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Daniel Alexander Beyer</investigator_full_name>
    <investigator_title>Priv.-Doz.Dr.med.habil.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

